Eric Easom An2 Therapeutics, Inc. (ANTX) insider trading activity

ANTX Quotes by TradingView

Eric Easom is Chief Executive Officer of AN2 Therapeutics, Inc.. Currently has a direct ownership of 256,380 shares of ANTX, which is worth approximately $269,199. The most recent transaction as insider was on Jun 02, 2025, when has been sold 10,000 shares (Common Stock) at a price of $1.07 per share, resulting in proceeds of $10,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 256K
4.06% 3M change
153.52% 12M change
Total Value Held $269,199

Eric Easom Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 02 2025
BUY
Open market or private purchase
$10,700 $1.07 p/Share
10,000 Added 3.75%
256,380 Common Stock
Feb 26 2025
BUY
Grant, award, or other acquisition
-
145,250 Added 37.09%
246,380 Common Stock
Mar 15 2024
BUY
Grant, award, or other acquisition
-
99,000 Added 49.47%
101,130 Common Stock
Jan 02 2024
SELL
Open market or private sale
$55,789 $20.09 p/Share
2,777 Reduced 56.59%
2,130 Common Stock
Nov 14 2022
SELL
Open market or private sale
$345 $15.04 p/Share
23 Reduced 0.47%
4,907 Common Stock
Nov 10 2022
SELL
Open market or private sale
$67,607 $15.32 p/Share
4,413 Reduced 47.23%
4,930 Common Stock
Nov 09 2022
SELL
Open market or private sale
$157,832 $15.61 p/Share
10,111 Reduced 67.33%
4,907 Common Stock
Nov 08 2022
SELL
Open market or private sale
$112,174 $15.9 p/Share
7,055 Reduced 31.96%
15,018 Common Stock
Nov 07 2022
SELL
Open market or private sale
$199,030 $16.31 p/Share
12,203 Reduced 71.32%
4,907 Common Stock
Nov 04 2022
SELL
Open market or private sale
$139,482 $15.8 p/Share
8,828 Reduced 34.04%
17,110 Common Stock
Nov 03 2022
SELL
Open market or private sale
$224,515 $15.85 p/Share
14,165 Reduced 35.32%
25,938 Common Stock
Nov 02 2022
SELL
Open market or private sale
$23,268 $15.07 p/Share
1,544 Reduced 23.93%
4,907 Common Stock
Oct 31 2022
SELL
Open market or private sale
$41,368 $15.39 p/Share
2,688 Reduced 29.41%
6,451 Common Stock
Oct 28 2022
SELL
Open market or private sale
$25,396 $15.09 p/Share
1,683 Reduced 25.54%
4,907 Common Stock
Oct 27 2022
SELL
Open market or private sale
$14,193 $15.36 p/Share
924 Reduced 12.3%
6,590 Common Stock
Oct 26 2022
SELL
Open market or private sale
$25,338 $15.1 p/Share
1,678 Reduced 25.48%
4,907 Common Stock
Oct 25 2022
SELL
Open market or private sale
$76,656 $15.95 p/Share
4,806 Reduced 42.19%
6,585 Common Stock
Oct 24 2022
SELL
Open market or private sale
$46,343 $16.17 p/Share
2,866 Reduced 20.1%
11,391 Common Stock
Oct 21 2022
SELL
Open market or private sale
$230,052 $16.49 p/Share
13,951 Reduced 73.98%
4,907 Common Stock
Oct 20 2022
SELL
Open market or private sale
$123,398 $16.92 p/Share
7,293 Reduced 27.89%
18,858 Common Stock
Mar 29 2022
BUY
Conversion of derivative security
-
4,907 Added 50.0%
4,907 Common Stock
EE

Eric Easom

Chief Executive Officer
Menlo Park, CA

Track Institutional and Insider Activities on ANTX

Follow AN2 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANTX shares.

Notify only if

Insider Trading

Get notified when an An2 Therapeutics, Inc. insider buys or sells ANTX shares.

Notify only if

News

Receive news related to AN2 Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ANTX